Wagner S - Search Results

1

Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study.

Park JW, Chen M, Colombo M, Roberts LR, Schwartz M, Chen PJ, Kudo M, Johnson P, Wagner S, Orsini LS, Sherman M. Park JW, et al. Among authors: wagner s. Liver Int. 2015 Sep;35(9):2155-66. doi: 10.1111/liv.12818. Epub 2015 Mar 25. Liver Int. 2015. PMID: 25752327 Free PMC article.

2

Risk Prediction Using Bayesian Networks: An Immunotherapy Case Study in Patients With Metastatic Renal Cell Carcinoma.

Gupta A, Arora P, Brenner D, Vanderpuye-Orgle J, Boyne DJ, Edmondson-Jones M, Parkhomenko E, Stevens W, Dudani S, Heng DYC, Wagner S, Borrill J, Wu E. Gupta A, et al. Among authors: wagner s. JCO Clin Cancer Inform. 2021 Mar;5:326-337. doi: 10.1200/CCI.20.00107. JCO Clin Cancer Inform. 2021. PMID: 33764818 Free PMC article.

3

Analysis of a Real-World Progression Variable and Related Endpoints for Patients with Five Different Cancer Types.

Torres AZ, Nussbaum NC, Parrinello CM, Bourla AB, Bowser BE, Wagner S, Tabano DC, George D, Miksad RA. Torres AZ, et al. Among authors: wagner s. Adv Ther. 2022 Jun;39(6):2831-2849. doi: 10.1007/s12325-022-02091-8. Epub 2022 Apr 17. Adv Ther. 2022. PMID: 35430670 Free PMC article.

4

Which Metrics Are Appropriate to Describe the Value of New Cancer Therapies?

Johnson P, Greiner W, Al-Dakkak I, Wagner S. Johnson P, et al. Among authors: wagner s. Biomed Res Int. 2015;2015:865101. doi: 10.1155/2015/865101. Epub 2015 Jun 16. Biomed Res Int. 2015. PMID: 26161418 Free PMC article. Review.

5

Accounting for Cured Patients in Cost-Effectiveness Analysis.

Othus M, Bansal A, Koepl L, Wagner S, Ramsey S. Othus M, et al. Among authors: wagner s. Value Health. 2017 Apr;20(4):705-709. doi: 10.1016/j.jval.2016.04.011. Epub 2016 Jun 9. Value Health. 2017. PMID: 28408015 Free article.

6

A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancer.

Roth JA, Yuan Y, Othus M, Danese M, Wagner S, Penrod JR, Ramsey SD. Roth JA, et al. Among authors: wagner s. J Med Econ. 2021 Jan-Dec;24(1):79-86. doi: 10.1080/13696998.2020.1857960. J Med Econ. 2021. PMID: 33334176 Free article.

7

Factors associated with complete adherence to HIV combination antiretroviral therapy.

Juday T, Gupta S, Grimm K, Wagner S, Kim E. Juday T, et al. Among authors: wagner s. HIV Clin Trials. 2011 Mar-Apr;12(2):71-8. doi: 10.1310/hct1202-71. HIV Clin Trials. 2011. PMID: 21498150

8

An expanded portfolio of survival metrics for assessing anticancer agents.

Karweit J, Kotapati S, Wagner S, Shaw JW, Wolfe SW, Abernethy AP. Karweit J, et al. Among authors: wagner s. Am J Manag Care. 2017 Jan;23(1):54-61. Am J Manag Care. 2017. PMID: 28141932 Free article. Review.

9

Evolving use of real-world evidence in the regulatory process: a focus on immuno-oncology treatment and outcomes.

O'Donnell JC, Le TK, Dobrin R, Higashi M, Pereira A, Wagner S, Yang A, Hukkelhoven M. O'Donnell JC, et al. Among authors: wagner s. Future Oncol. 2021 Jan;17(3):333-347. doi: 10.2217/fon-2020-0591. Epub 2020 Oct 19. Future Oncol. 2021. PMID: 33074018 Free article. Review.

10

Patient-reported outcomes with nivolumab in advanced solid cancers.

Tykodi SS, Schadendorf D, Cella D, Reck M, Harrington K, Wagner S, Shaw JW. Tykodi SS, et al. Among authors: wagner s. Cancer Treat Rev. 2018 Nov;70:75-87. doi: 10.1016/j.ctrv.2018.08.001. Epub 2018 Aug 2. Cancer Treat Rev. 2018. PMID: 30125799 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,890 results

Search Page